Skip to Main Content
Legislation Search

H.R. 2286: American Genetic Privacy Act of 2025

The American Genetic Privacy Act of 2025 aims to restrict the sharing of certain genetic information with the People's Republic of China. This legislation outlines the following key components:

Prohibition on Disclosure

  • Sales of Information: No individual or organization is allowed to sell or offer to sell genetic information to the People's Republic of China or to any entity that is influenced, controlled, or owned by the People's Republic of China.
  • Disclosures by DNA Testing Services: Commercial DNA testing services are prohibited from disclosing genetic information to the People's Republic of China or to any entities influenced, controlled, or owned by it.

Enforcement Mechanism

The Federal Trade Commission (FTC) will be responsible for enforcing these prohibitions. A violation of this law will be treated as a violation of existing regulations under the Federal Trade Commission Act regarding unfair or deceptive practices.

  • The FTC will have the same powers and jurisdiction to enforce this section as it does under its existing authority, enabling it to impose penalties for violations.

Definitions

  • Commercial DNA Testing Service: A service that provides genealogical or ancestry-related information based on an individual’s DNA.
  • Covered Information: This refers to genetic information originally acquired from an individual through the use of a commercial DNA testing service.
  • Genetic Information: Information regarding the genetic tests of an individual.
  • Genetic Test: Defined as per existing law under the Genetic Information Nondiscrimination Act of 2008.

Relevant Companies

  • AMGN (Amgen Inc.): As a biotechnology company involved in genetic research, Amgen may be affected by regulations related to the sharing of genetic information and how they conduct research and collaborations.
  • ILMN (Illumina Inc.): As a leader in genetic sequencing technology, the impact on legal and operational frameworks regarding genetic data privacy could significantly affect their business operations and data sharing agreements.
  • EXAS (Exact Sciences Corporation): This company focuses on cancer screening and genetic testing and may face implications regarding how it handles genetic data and compliance with new regulations.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

4 bill sponsors

Actions

2 actions

Date Action
Mar. 24, 2025 Introduced in House
Mar. 24, 2025 Referred to the House Committee on Energy and Commerce.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 +1.41%
Congress pfp
Emily Randall D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +18.86%
Congress pfp
Virginia Foxx R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +15.13%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Partial) $1,001 - $15,000
Oct 10, 2024 Sep 17, 2024 -10.17%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $15,001 - $50,000
Sep 24, 2024 Sep 03, 2024 -40.68%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $15,001 - $50,000
Oct 01, 2024 Aug 30, 2024 -39.22%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $50,001 - $100,000
Aug 20, 2024 Aug 07, 2024 -12.80%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2024 Aug 02, 2024 -15.75%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -6.68%
Congress pfp
Josh Gottheimer D / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION - COMMON STOCK
Sale $1,001 - $15,000
Jun 08, 2024 May 10, 2024 -23.37%
Congress pfp
Thomas H. Kean, Jr. R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 30, 2024 Apr 19, 2024 -45.70%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $1,001 - $15,000
Mar 22, 2024 Mar 11, 2024 -51.76%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2024 Mar 11, 2024 -51.76%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $1,001 - $15,000
Mar 07, 2024 Feb 12, 2024 -54.22%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 07, 2024 Feb 12, 2024 -54.22%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $1,001 - $15,000
Mar 07, 2024 Feb 12, 2024 -54.22%
Congress pfp
Josh Gottheimer D / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION - COMMON STOCK
Sale $1,001 - $15,000
Mar 07, 2024 Feb 01, 2024 -42.57%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -19.12%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -19.08%
Congress pfp
Michael C. Burgess R / House
AMGN logo
AMGN AMGEN INC.
Sale $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -18.25%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC.
Sale $1,001 - $15,000
Jan 22, 2024 Jan 02, 2024 -59.75%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC.
Purchase $1,001 - $15,000
Jan 22, 2024 Jan 02, 2024 -59.75%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC.
Purchase $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -59.75%
Congress pfp
Kevin Hern R / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2024 Jan 02, 2024 -55.13%
Congress pfp
Josh Gottheimer D / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION
Sale $1,001 - $15,000
Dec 08, 2023 Nov 13, 2023 -49.49%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -23.91%
Congress pfp
Josh Gottheimer D / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION
Purchase $1,001 - $15,000
Nov 11, 2023 Oct 16, 2023 -58.68%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -20.14%
Congress pfp
Josh Gottheimer D / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION
Sale $1,001 - $15,000
Oct 15, 2023 Sep 15, 2023 -64.16%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 21, 2024 Jul 14, 2023 +4.69%
Congress pfp
Shelley Moore Capito R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $1,001 - $15,000
Jul 17, 2023 Jun 12, 2023 +6.19%
Congress pfp
Josh Gottheimer D / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION
Sale $1,001 - $15,000
Jun 11, 2023 May 01, 2023 -61.17%
Congress pfp
Josh Gottheimer D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Jun 11, 2023 May 01, 2023 -10.68%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -11.00%